Transfection Reagents and Equipment Market Growth, Forecast to 2026

Transfection Reagents and Equipment market is expected to grow from USD 10.46 billion in 2019 to USD 17.87 billion by 2026 at a CAGR of 7.95% from 2020 to 2026.

Transfection is a technique that is employed to insert genetic material like DNA or RNA, into mammalian cells. Transfection reagents and equipment are utilized in this process, wherein reagents contain the genetic material and equipment used as a delivery for the genetic material. This introduction of genetic material into the specified cells are often administered by various chemical, biological, or physical methods. The growth of the market is often attributed to increasing technological advancements in transfections equipment and rising research and development spending alongside research activities by pharmaceutical and biotechnology companies. Moreover, rising demand for synthetic genes is probably going to feature new opportunities for the worldwide market within the forecast period. This growth is often attributed to factors like advancements in transfection technology, global alliances among leading research institutes to trigger drug discovery, increase in R&D spending and research activities by pharmaceutical and biotechnology companies, increase in demand for synthetic genes, and rising incidence of cancer. Moreover, the development of huge scale transfections, rising demand for protein therapeutics, and emerging markets across India and China are likely to make opportunities for players operating within the market.

View Complete Report: @ https://marketreportslibrary.com/report/he0245/transfection-reagents-and-equipment-market

The global Transfection Reagents and Equipment market has been segmented as below:

By Product

• Reagents

• Instruments

By Method

• Biochemical

• Calcium Phosphate

• Lipofection

• DEAE-dextran

• Dendrimers

• Physical

• Electroporation

• Nucleofection

• Others

By End-User

• Academic & Research Institutes

• Pharmaceutical & Biotechnology Companies

By Application

• Biomedical Research

• Gene Expression Studies

• Cancer Research

• Transgenic Model

• Protein Production

• Therapeutic Delivery

By Region

• Europe

• North America

• Asia Pacific

• Rest of The World

Competitive Rivalry

Thermo Fisher Scientific Inc. (Life Technologies), Promega Corporation, Qiagen N.V., F. Hoffmann-La Roche Ltd, Bio–Rad Laboratories, Inc., Maxcyte, Inc., Lonza Group Ltd., Merck KGaA, Polyplus-Transfection Sa, Mirus Bio LLC., and others are among the major players in the market. The companies studied in terms of product strategy and various n several growths and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.

Request a Sample of this Report: @ https://marketreportslibrary.com/request/sample/he0245/transfection-reagents-and-equipment-market

Explore other reports from ”Healthcare” sector @ https://marketreportslibrary.com/category/healthcare

Contact Us:

SRR residency Mig-59, 

7th phase Kphb colony 

Near prathibha school 

Hyderabad, 500072

[email protected]